Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-27T21:50:28.520Z Has data issue: false hasContentIssue false
  • English
  • Français

Ischemic Brain Infarction

Published online by Cambridge University Press:  07 November 2014

Deborah R. Horowitz
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Introduction
Information
CNS Spectrums , Volume 5 , Issue 3: Neurologic and Psychiatric Sequelae of Stroke , March 2000 , pp. 21
Copyright
Copyright © Cambridge University Press 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Broderick, J, Brott, T, Kothari, R, et al.The greater Cincinnati/Northern Kentucky Stroke Study. Stroke. 1998;29:415–421.Google Scholar
2.The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–1587.CrossRefGoogle Scholar
3.Clark, WM, Wissman, S, Albers, GW, et al.Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. JAMA. 1999;282:2019–2026.CrossRefGoogle ScholarPubMed